Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH TrialIseult M Browne, Javier Pascual, Rosalind J Cutts, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2017
Long-Term Follow-Up of the Intergroup Exemestane StudyJames P Morden, Isabel Alvarez, Gianfilippo Bertelli, et al.The Lancet. Oncology|June 11, 2017
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trialDavid Cameron, James P Morden, Peter Canney, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2023
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast CancerPamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.JAMA Oncology|July 15, 2021
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical TrialR Charles Coombes, Holly Tovey, Lucy Kilburn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2020
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast CancerAdrian Murray Brunt, Joanne S Haviland, Mark Sydenham, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2025
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-studyA Murray Brunt, Fay H Cafferty, Duncan Wheatley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)Alistair Ring, Lucy S Kilburn, Alex Pearson, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2011
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015), Rajiv K Agrawal, Abdulla Alhasso, et al.Pageof 10